Handelsbanken Fonder’s BioTelemetry, Inc. BEAT Stock Holding History

Handelsbanken Fonder’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,600	Closed	-$476K	–	1607
2020 Q4	$476K	Hold	6,600	–	–	﹤0.01%	1190
2020 Q3	$301K	Hold	6,600	–	–	﹤0.01%	1241
2020 Q2	$298K	Buy	+6,600	New	+$296K	﹤0.01%	1225

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Handelsbanken Fonder's BEAT Position: Q1 2021 in Review

Handelsbanken Fonder sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,600 shares — an estimated $476K sold.

Handelsbanken Fonder first reported a position in BEAT in Q2 2020 and held it in 3 quarters. The position peaked at $476K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Handelsbanken Fonder reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Handelsbanken Fonder sold 6,600 BioTelemetry, Inc. shares in Q1 2021, an estimated $476K.
Handelsbanken Fonder first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 3 quarters.
Handelsbanken Fonder's BioTelemetry, Inc. position peaked at $476K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Handelsbanken Fonder's 13F filing for Q1 2021, filed 29 Apr 2021.